Both in Pharmaceuticals
Bristol-Myers Squibb vs Abbott Laboratories
Over the past year BMY returned +35.8% and ABT returned −14.2%; their daily moves had a correlation of 0.22.
BMY +35.8% ABT −14.2%Growth of $1, one year, split-adjusted
| Metric | BMY | ABT |
|---|---|---|
| Price | $62.48 | $106.20 |
| Market cap | $127.71B | $183.77B |
| Today | +1.78% | +1.56% |
| 1 month | +1.7% | +9.8% |
| 6 months | +7.3% | +18.7% |
| Year to date | +15.8% | −15.2% |
| 1 year | +46.7% | −14.7% |
| Revenue growth (YoY) | +5.7% | +13.0% |
| Gross margin | 71.3% | 57.7% |
| Net margin | 25.6% | 7.4% |
| P/E (TTM) | 13.8× | 33.9× |
| Price / sales | 2.6× | 3.9× |
| Net cash | -$32.05B | -$27.00B |
| Dividend yield | 4.03% | 2.37% |
| Volatility (60d) | 27.3% | 21.3% |
| Short % of float | 2.4% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).